Best Myeloma Treatment Clinics and Prices in India for Australians

India hosts several high-performing hospitals for myeloma treatment. These include JCI-accredited facilities like Apollo Hospital Indraprastha in Delhi and Artemis Hospitals in Gurgaon. These centres specialise in chemotherapy, immunotherapy, and bone marrow transplants. Most major Indian oncology hubs provide multi-disciplinary care under one roof.

• Clinical accreditation: Apollo Hospital and Artemis Hospitals hold JCI accreditation for quality and safety.
• Diagnostics: Clinics use Sentinel lymph node biopsy and haematologist consultations for staging.
• Specialist expertise: Dr Girish Badarkhe at HCG Manavata Cancer Centre performs complex haploidentical transplants.
• Institutional scale: Medanta Hospital in Gurgaon houses 1,600 beds and is NABH-accredited.

Bookimed Expert Insight: Many patients focus on Delhi or Mumbai. However, centres in Nashik like HCG Manavata Cancer Centre serve 75,000 patients each year. This high volume often leads to faster diagnostic turnaround times. It was also the first NABH-accredited cancer care facility in Maharashtra.

Patient Consensus: Patients note that Mumbai and Delhi hospitals have extremely dedicated doctors. These doctors manage over 1,000 transplants. They recommend gathering full medical records before seeking second opinions from these experienced haematologists.

Multiple myeloma treatment in India focuses on induction therapy and autologous stem cell transplants. Advanced immunotherapy is also used. Patients access targeted protocols using proteasome inhibitors and monoclonal antibodies. Specialist centres like HCG Manavata Cancer Centre and Artemis Hospitals provide these treatments. They follow international JCI and NABH quality standards.

• Induction therapy: Doctors use drug combinations to reduce cancer cell count before further treatment.
• Stem cell transplant: Eligible patients often receive autologous, allogeneic, or haploidentical bone marrow transplants.
• Advanced immunotherapy: CAR T-cell therapy is available for complex or relapsed blood cancer cases.
• Precision radiation: Systems like Tomotherapy-H and Linear Accelerators deliver targeted radiation to bone lesions.
• Diagnostic monitoring: Specialists use PET-CT and MRI scans to track treatment response and staging.

Bookimed Expert Insight: India has become a hub for complex haematology. This is due to major networks like Manipal and Apollo managing over 1,000,000 patients each year. Because of this volume, specialists like Dr Girish Badarkhe gain experience in rare haploidentical transplants. These procedures are often harder to access in smaller regional hospitals elsewhere.

Patient Consensus: Patients in India often start with a four-drug induction regimen including Bortezomib and Dexamethasone. Many note that lowering steroid doses helps manage side effects during stem cell transplant preparation.

CAR-T cell therapy is available for myeloma in India at major oncology hospitals. Indian centres use indigenous CAR-T technologies and international protocols for refractory blood cancers. Doctors such as Dr Girish Badarkhe at HCG Manavata Cancer Centre perform these procedures. They treat complex cases.

• Clinical applications: Specialists use CAR-T for blood cancers that have not responded to standard treatments.
• Indigenous technology: India uses homegrown CAR-T programs, making cellular therapy more accessible and affordable.
• Specialist expertise: Dr Girish Badarkhe performs CAR-T therapy within NABH-accredited facilities specialising in haematology.
• Supporting treatments: Clinics offer related procedures including allogeneic and haploidentical bone marrow transplants where necessary.

Bookimed Expert Insight: Indian clinics such as HCG Manavata Cancer Centre have a distinct advantage. They combine CAR-T with TomoTherapy-H and Versa HD radiation. This multi-modal approach manages complex myeloma cases more effectively than single-therapy protocols. This level of integrated care is often unavailable at smaller regional centres.

Patient Consensus: Patients in India find the three-month recovery period manageable. It feels less intense than traditional stem cell transplants. They highlight the importance of preparing for low immune function and potential IgG infusions. These are common after the CAR-T cells are administered.

Leading Indian medical centres provide the latest myeloma treatments. These include CAR T-cell therapy and immunotherapies like daratumumab. Major hospitals in Delhi, Bengaluru and Chennai specialise in these targeted protocols. Australian patients often access clinical trials for emerging agents like mezigdomide.

• Specialised care: Fortis Hospital Gurugram and HCG Manavata Cancer Centre host dedicated myeloma units.
• Advanced immunotherapy: Centres routinely use four-drug regimens including daratumumab for relapsed and new cases.
• Cellular therapy: Specialists like Dr Girish Badarkhe offer CAR T-cell therapy for refractory cancers.
• Precision radiation: 4D radiotherapy and TomoTherapy-H target tumours while protecting healthy patient tissue.

Bookimed Expert Insight: India ranks 6th globally for medical requests on Bookimed. Top centres like Manipal Hospitals serve over 2,000,000 patients annually. This massive case volume allows Indian specialists to manage complex myeloma cases with highly refined protocols. Australian patients benefit from this deep clinical experience in major metropolitan hubs.

Patient Consensus: Patients note that standard quadruplet therapy is readily available in India. Clinical trials provide a vital pathway to access newer targeted medications at reduced costs. Seeking a compassionate specialist early is essential for managing side effects and long-term recovery.

Myeloma treatment in India typically lasts 6 to 7 months for the main phases. Initial diagnostics take 5 to 7 days. This is followed by 3 to 6 months of induction chemotherapy. A stem cell transplant requires 3 to 4 weeks of inpatient care.

• Diagnostic phase: Haematologists use PET-CT scans and biopsies, usually completed within 1 week.
• Induction therapy: Outpatient chemotherapy or immunotherapy cycles last approximately 3 to 6 months.
• Transplant stay: Autologous stem cell transplants involve 3 to 4 weeks of hospitalisation.
• Recovery period: Initial recovery takes 2 to 3 weeks followed by outpatient maintenance.

Bookimed Expert Insight: Indian clinics like HCG Manavata Cancer Centre and Apollo Hospital handle massive patient volumes. This experience allows specialists like Dr Girish Badarkhe to manage complex haploidentical transplants. Their high caseload often leads to faster diagnostic turnaround times compared to smaller facilities.

Patient Consensus: Patients note significant blood report improvements after starting therapy in India. These improvements appear within 4 to 6 weeks. The first 6 weeks post-transplant are physically taxing. However, most patients regain their stamina and reach remission by the 6-month mark.

Patients can obtain expert second opinions for myeloma from leading Indian haematologists. Specialist centres provide reviews for complex cases, including refractory blood cancers and transplant eligibility. Consultations with haematologists typically cost between A$60 and A$70. Many facilities offer virtual reviews of lab results and bone marrow biopsies.

• Accredited facilities: JCI and NABH-accredited centres like Manipal Hospitals serve 2,000,000 patients annually.
• Advanced therapies: Specialists provide second opinions on CAR T-cell therapy and haploidentical stem cell transplants.
• Precision diagnostics: Centres use PET-CT and US-FDA-audited research protocols to confirm myeloma stages.
• Expert specialists: Doctors like Dr Girish Badarkhe at HCG Manavata have over 10 years' experience.

Bookimed Expert Insight: Indian specialists often manage exceptionally high patient volumes, which is vital for rare myeloma subtypes. For instance, Apollo Hospitals serves over 1,000,000 international patients annually. These massive datasets allow haematologists to identify patterns in treatment resistance. Centres with lower volumes might miss these patterns.

Patient Consensus: Patients note that second opinions in India help clarify if autologous transplants are necessary. These procedures are intensive. Virtual consultations are a popular way to access specialists early, before bone damage occurs.

International patients in India benefit from dedicated medical coordination and visa assistance. They also receive specialised logistical support at JCI-accredited facilities. Specialised desks manage airport transfers and local accommodation. Multilingual staff and personal coordinators at clinics like Aster CMI Hospital simplify communication. They assist during complex bone marrow transplant procedures.

• Clinic accreditation: Major hubs like Artemis Hospitals and Apollo Hospital Indraprastha hold JCI certification.
• Logistical assistance: Aster CMI Hospital provides free airport transfers and dedicated personal coordinators for patients.
• Dietary support: Global Hospital Mumbai offers specialised meals tailored to specific religious and dietary requirements.
• Language services: International patients at Manipal Goa Hospital have access to professional interpreters and accommodations.
• Research access: HCG Manavata Cancer Centre features a research institute audited by the US-FDA.

Bookimed Expert Insight: Clinics in Mumbai and Bengaluru often achieve higher success. They do so by combining standard induction therapy with advanced diagnostics. Manipal Goa Hospital uses IBM Watson for Oncology with 96% accuracy for lung cancer. This reflects the high-tech diagnostic support available for complex myeloma staging.

Patient Consensus: Patients value the clinical expertise in stem cell therapy. They also find the induction protocols align closely with Australian and international standards. Support for housing and visas is available. However, patients note it is important to proactively request palliative care for side effect management.